R Chakrabarti, G R Fearnley. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdultAge FactorsBlood Platelets/drug effectsCholesterol/bloodDrug SynergismEthylestrenol/adverse effectsEthylestrenol/pharmacologyEthylestrenol/therapeutic useFibrinogen/metabolismFibrinolysis/drug effectsHumansMaleMiddle AgedMyocardial Infarction/drug therapyMyocardial Infarction/prevention & controlPhenformin/adverse effectsPhenformin/pharmacologyPhenformin/therapeutic usePotassium/metabolismRecurrenceTime Factors
Substances： See more » FibrinogenCholesterolEthylestrenolPhenforminPotassium
Year: 1972 PMID： 4115736 DOI： 10.1016/s0140-6736(72)91956-3
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321